KYC is one time exercise with a SEBI registered intermediary while dealing in securities markets (Broker/ DP/ Mutual Fund etc.). | No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.   |   Prevent unauthorized transactions in your account – Update your mobile numbers / email ids with your stock brokers. Receive information of your transactions directly from exchange on your mobile / email at the EOD | Filing Complaint on SCORES - QUICK & EASY a) Register on SCORES b) Mandatory details for filing complaints on SCORE - Name, PAN, Email, Address and Mob. no. c) Benefits - speedy redressal & Effective communication   |   BSE Prices delayed by 5 minutes...<< Prices as on Jan 29, 2026 - 3:59PM >>  ABB India 5477.9  [ 8.56% ]  ACC 1679.2  [ -0.37% ]  Ambuja Cements 536.3  [ 0.45% ]  Asian Paints 2418.3  [ -3.69% ]  Axis Bank 1364  [ 3.29% ]  Bajaj Auto 9494.75  [ 0.63% ]  Bank of Baroda 302.8  [ -1.09% ]  Bharti Airtel 1968.1  [ 0.56% ]  Bharat Heavy 260.65  [ 0.39% ]  Bharat Petroleum 366.75  [ 1.20% ]  Britannia Industries 5729.05  [ -0.28% ]  Cipla 1323.35  [ -0.37% ]  Coal India 455.5  [ 2.53% ]  Colgate Palm 2115  [ -1.79% ]  Dabur India 506.8  [ -1.72% ]  DLF 639.05  [ 2.18% ]  Dr. Reddy's Labs 1209  [ -1.25% ]  GAIL (India) 167.2  [ -0.54% ]  Grasim Industries 2837.8  [ -0.18% ]  HCL Technologies 1722.8  [ -0.44% ]  HDFC Bank 935.35  [ 0.29% ]  Hero MotoCorp 5587.5  [ 1.57% ]  Hindustan Unilever 2351.4  [ -1.22% ]  Hindalco Industries 1022.8  [ 2.41% ]  ICICI Bank 1383.05  [ 1.14% ]  Indian Hotels Co. 664.65  [ 1.27% ]  IndusInd Bank 899.65  [ -0.19% ]  Infosys 1660.85  [ -0.33% ]  ITC 318.75  [ -0.78% ]  Jindal Steel 1155.7  [ 3.28% ]  Kotak Mahindra Bank 413.1  [ 0.17% ]  L&T 3938  [ 3.81% ]  Lupin 2132.3  [ 0.50% ]  Mahi. & Mahi 3382.6  [ -1.92% ]  Maruti Suzuki India 14517.8  [ -2.41% ]  MTNL 30.85  [ -1.44% ]  Nestle India 1288.35  [ -0.34% ]  NIIT 75.76  [ 0.60% ]  NMDC 84.21  [ 3.31% ]  NTPC 357.55  [ 2.69% ]  ONGC 275.1  [ 2.40% ]  Punj. NationlBak 125.4  [ 0.72% ]  Power Grid Corpo 260.3  [ 0.21% ]  Reliance Industries 1395  [ -0.15% ]  SBI 1065.85  [ 0.29% ]  Vedanta 764.2  [ 3.68% ]  Shipping Corpn. 223.15  [ 1.18% ]  Sun Pharmaceutical 1590.15  [ -1.24% ]  Tata Chemicals 719.6  [ -1.05% ]  Tata Consumer Produc 1108.45  [ -2.09% ]  Tata Motors Passenge 351.2  [ 3.16% ]  Tata Steel 202  [ 4.23% ]  Tata Power Co. 366.55  [ 3.24% ]  Tata Consultancy 3148.45  [ -1.61% ]  Tech Mahindra 1769.05  [ 0.37% ]  UltraTech Cement 12728  [ -0.32% ]  United Spirits 1329  [ 0.13% ]  Wipro 240.05  [ 1.12% ]  Zee Entertainment En 82.14  [ -2.18% ]  
  • Share Prices
  • Tools
  • News
  • Company Details
  • Financial Data
  • Results
  • Key Financial Ratios
  • Reports
  • Corporate Announcements
  • Equity History

    • Company Information

    Indian Indices
    • Loading....

    Global Indices
    • Loading....

    Forex
    • Loading....

    ALIVUS LIFE SCIENCES LTD.

    29 January 2026 | 03:59

    Industry >> Pharmaceuticals

    Select Another Company

    ISIN No INE03Q201024 BSE Code / NSE Code 543322 / ALIVUS Book Value (Rs.) 245.68 Face Value 2.00
    Bookclosure 01/09/2025 52Week High 1251 EPS 39.57 P/E 23.76
    Market Cap. 11537.22 Cr. 52Week Low 819 P/BV / Div Yield (%) 3.83 / 0.00 Market Lot 1.00
    Security Type Other

    History of Company

    The company history sections lists out major chronological events that happened to the company.
    The Company was incorporated as `Zorg Laboratories Private Limited', a private limited company under the Companies Act, 1956 on June 23, 2011 at Pune and was granted the certificate of incorporation by the RoC. the Company was acquired by Glenmark Pharmaceuticals Limited pursuant to the Share Purchase Agreement dated July 4, 2018. For further details, please see - "Details regarding material acquisitions or divestments of business/ undertakings, mergers, amalgamations or any revaluation of assets, in the last 10 years - Acquisition by Glenmark Pharmaceuticals Limited" on page 151. Pursuant to the acquisition, the name of the Company was changed to `Glenmark Life Sciences Private Limited' by way of a special resolution passed by the shareholders of the Company on July 25, 2018 and a fresh certificate of incorporation dated August 10, 2018 was issued by the RoC. A shareholders' resolution was passed on August 13, 2018 to convert the Company from a private limited company to a public limited company and a fresh certificate of incorporation dated August 28, 2018 was issued by the RoC. Thereafter, the business of active pharmaceutical ingredients was acquired by the Company from the Promoter pursuant to the Business Purchase Agreement.

    Major events and milestones of the Company :
    2002
    - The Promoter established its API business
    - Established manufacturing plant at Kurkumbh, Maharashtra

    2003
    - First product registered with US-FDA
    - Acquired GlaxoSmithKline's (GSK) API manufacturing plant in Ankleshwar, Gujarat

    2004
    - Commenced manufacturing at Mohol, Maharashtra

    2008
    - Ankleshwar plant at Gujarat inspected by US-FDA

    2012
    - Ankleshwar plant inspected by PMDA and AFSSAPS

    2013
    - Commenced manufacturing at Dahej, Gujarat
    - Ankleshwar plant inspected by COFEPRIS

    2015
    - Dahej plant inspected by US-FDA

    2016
    - Dahej plant inspected by PMDA Japan

    2018
    - Dahej plant inspected by EDQM, ANSM and US-FDA
    - Mohol plant inspected by US-FDA

    2019
    - The API business was spun off into the Company
    - Ankleshwar plant inspected by US-FDA, Health Canada and PMDA, Japan

    2021
    - Achieved milestone of 403 cumulative drug master files (DMF) registrations across multiple markets globally

    2023 -The Company had announced that its board had given the green light to divest a 75% stake in its subsidiary GLS to Nirma Ltd for a total of Rs 5,651.5 crore.

    2025 -The Company name has changed from Glenmark Life Sciences Ltd to Alivus Life Sciences Ltd. -The Company Informed regarding Agreement and Power Supply Agreement between Alivus Life Sciences Ltd. and Torrent Urja 19 Private Ltd.

    Way2Wealth Brokers Private Limited - CIN U67120KA2000PTC027628 Stock Broking: SEBI Regn No.: INZ000178638 | Exchange Membership ID: NSE: 11502, BSE: 3117, MSEI:51000, MCX: 56730 Depository Participant: SEBI Regn No. IN-DP-472-2020 | CDSL ID: 12062900 & 12031500, NSDL ID: IN303077 | Research Analyst: SEBI Regn No. INH200008705 | PMS: SEBI Regn No.INP000000829 | Register with AMFI ARN: 77558 (Date of Initial registration - 8th Dec 2009, Date of expiry - 24th Jan 2027) | PFRDA: POP226012019

    Way2Wealth Commodities Private Limited - CIN U51229KA2006PTC039880 Stock Broking: SEBI Regn No.: INZ000049130 | Exchange Membership ID: NCDEX : 00908

    Copyrights @ 2014 © Way2Wealth Brokers Pvt. Ltd. All rights reserved

    Designed, developed and content provided by  Dion

    Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.